Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Inhibition of MT1-MMP proteolytic function and ERK1/2 signalling influences cell migration and invasion through changes in MMP-2 and MMP-9 levels.

Cepeda MA, Evered CL, Pelling JJH, Damjanovski S.

J Cell Commun Signal. 2017 Jun;11(2):167-179. doi: 10.1007/s12079-016-0373-3. Epub 2017 Jan 9.

2.

Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor.

Stawowczyk M, Wellenstein MD, Lee SB, Yomtoubian S, Durrans A, Choi H, Narula N, Altorki NK, Gao D, Mittal V.

Neoplasia. 2017 Feb;19(2):55-64. doi: 10.1016/j.neo.2016.11.005. Epub 2016 Dec 23.

3.

Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.

Cepeda MA, Pelling JJ, Evered CL, Williams KC, Freedman Z, Stan I, Willson JA, Leong HS, Damjanovski S.

Mol Cancer. 2016 Oct 18;15(1):65.

4.

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.

Vos MC, Hollemans E, Ezendam N, Feijen H, Boll D, Pijlman B, van der Putten H, Klinkhamer P, van Kuppevelt TH, van der Wurff AA, Massuger LF.

J Ovarian Res. 2016 Sep 2;9(1):53. doi: 10.1186/s13048-016-0262-7.

5.

New insight into the role of MMP14 in metabolic balance.

Mori H, Bhat R, Bruni-Cardoso A, Chen EI, Jorgens DM, Coutinho K, Louie K, Bowen BB, Inman JL, Tecca V, Lee SJ, Becker-Weimann S, Northen T, Seiki M, Borowsky AD, Auer M, Bissell MJ.

PeerJ. 2016 Jul 13;4:e2142. doi: 10.7717/peerj.2142. eCollection 2016.

6.

Bilayer Membrane Modulation of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Structure and Proteolytic Activity.

Cerofolini L, Amar S, Lauer JL, Martelli T, Fragai M, Luchinat C, Fields GB.

Sci Rep. 2016 Jul 13;6:29511. doi: 10.1038/srep29511.

7.

Cortactin promotes exosome secretion by controlling branched actin dynamics.

Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM.

J Cell Biol. 2016 Jul 18;214(2):197-213. doi: 10.1083/jcb.201601025. Epub 2016 Jul 11.

8.

Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo.

Yang H, Guan L, Li S, Jiang Y, Xiong N, Li L, Wu C, Zeng H, Liu Y.

Oncotarget. 2016 Mar 29;7(13):16227-47. doi: 10.18632/oncotarget.7583.

9.

High-Throughput Multiplexed Peptide-Centric Profiling Illustrates Both Substrate Cleavage Redundancy and Specificity in the MMP Family.

Kukreja M, Shiryaev SA, Cieplak P, Muranaka N, Routenberg DA, Chernov AV, Kumar S, Remacle AG, Smith JW, Kozlov IA, Strongin AY.

Chem Biol. 2015 Aug 20;22(8):1122-33. doi: 10.1016/j.chembiol.2015.07.008. Epub 2015 Aug 6.

10.

Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas.

Cathcart J, Pulkoski-Gross A, Cao J.

Genes Dis. 2015 Mar 1;2(`1):26-34.

11.

Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases.

Li YY, Zhou CX, Gao Y.

Am J Cancer Res. 2015 Jan 15;5(2):514-29. eCollection 2015.

12.

The Role of CD44 in Disease Pathophysiology and Targeted Treatment.

Jordan AR, Racine RR, Hennig MJ, Lokeshwar VB.

Front Immunol. 2015 Apr 21;6:182. doi: 10.3389/fimmu.2015.00182. eCollection 2015. Review.

13.

Expression of matrix metalloproteinases in bovine luteal cells induced by prostaglandin F2α, interferon γ and tumor necrosis factor α.

Abe H, Sakumoto R, Okuda K.

J Reprod Dev. 2015;61(4):277-86. doi: 10.1262/jrd.2014-150. Epub 2015 Apr 30.

14.

A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells.

Assent D, Bourgot I, Hennuy B, Geurts P, Noël A, Foidart JM, Maquoi E.

PLoS One. 2015 Mar 16;10(3):e0116006. doi: 10.1371/journal.pone.0116006. eCollection 2015.

15.

EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.

Lu A, Zuo C, He Y, Chen G, Piao L, Zhang J, Xiao B, Shen Y, Tang J, Kong D, Alberti S, Chen D, Zuo S, Zhang Q, Yan S, Fei X, Yuan F, Zhou B, Duan S, Yu Y, Lazarus M, Su Y, Breyer RM, Funk CD, Yu Y.

J Clin Invest. 2015 Mar 2;125(3):1228-42. doi: 10.1172/JCI77656. Epub 2015 Feb 9.

16.

Receptor for advanced glycation end products - membrane type1 matrix metalloproteinase axis regulates tissue factor expression via RhoA and Rac1 activation in high-mobility group box-1 stimulated endothelial cells.

Sugimoto K, Ohkawara H, Nakamura Y, Takuwa Y, Ishibashi T, Takeishi Y.

PLoS One. 2014 Dec 9;9(12):e114429. doi: 10.1371/journal.pone.0114429. eCollection 2014.

18.
19.

Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression.

Pahwa S, Stawikowski MJ, Fields GB.

Cancers (Basel). 2014 Feb 17;6(1):416-35. doi: 10.3390/cancers6010416.

20.

MMP regulation of corneal keratocyte motility and mechanics in 3-D collagen matrices.

Zhou C, Petroll WM.

Exp Eye Res. 2014 Apr;121:147-60. doi: 10.1016/j.exer.2014.02.002. Epub 2014 Feb 14.

Supplemental Content

Support Center